Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Correlation Between Immune Invasion and SARS-COV-2 Entry Protein ADAM17 in Cancer Patients by Bioinformatic Analysis. | Front Immunol | 2022 | 35720350 | PubTator, text mining | PubMed |
| Inflammation-Related LncRNAs Signature for Prognosis and Immune Response Evaluation in Uterine Corpus Endometrial Carcinoma. | Front Oncol | 2022 | 35719911 | PubTator, text mining | PubMed |
| Oncolytic Viruses: Immunotherapy Drugs for Gastrointestinal Malignant Tumors. | Front Cell Infect Microbiol | 2022 | 35719333 | PubTator, text mining | PubMed |
| A Single-Cell Atlas of Tumor-Infiltrating Immune Cells in Pancreatic Ductal Adenocarcinoma. | Mol Cell Proteomics | 2022 | 35718340 | PubTator, text mining | PubMed |
| An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situ. | Mol Ther | 2022 | 35715953 | PubTator, text mining | PubMed |
| Role of TNFSF9 bidirectional signal transduction in antitumor immunotherapy. | Eur J Pharmacol | 2022 | 35714694 | PubTator, text mining | PubMed |
| T-cell trans-synaptic vesicles are distinct and carry greater effector content than constitutive extracellular vesicles. | Nat Commun | 2022 | 35710644 | PubTator, text mining | PubMed |
| Vγ9Vδ2 T cells expressing a BCMA-Specific chimeric antigen receptor inhibit multiple myeloma xenograft growth. | PLoS One | 2022 | 35709135 | PubTator, text mining | PubMed |
| Lower Expression of TWEAK is Associated with Poor Survival and Dysregulate TIICs in Lung Adenocarcinoma. | Dis Markers | 2022 | 35707713 | PubTator, text mining | PubMed |
| Identification of a novel prognostic signature for HCC and analysis of costimulatory molecule-related lncRNA AC099850.3. | Sci Rep | 2022 | 35705628 | PubTator, text mining | PubMed |
| Adaptive stress response genes associated with breast cancer subtypes and survival outcomes reveal race-related differences. | NPJ Breast Cancer | 2022 | 35697736 | PubTator, text mining | PubMed |
| Characterization of m6A Methylation Modification Patterns in Colorectal Cancer Determines Prognosis and Tumor Microenvironment Infiltration. | J Immunol Res | 2022 | 35692505 | PubTator, text mining | PubMed |
| The immune landscape of solid pediatric tumors. | J Exp Clin Cancer Res | 2022 | 35690832 | PubTator, text mining | PubMed |
| An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer. | Front Oncol | 2022 | 35686109 | PubTator, text mining | PubMed |
| Antigen-Specific T Cell Immunotherapy Targeting Claudin18.2 in Gastric Cancer. | Cancers (Basel) | 2022 | 35681738 | PubTator, text mining | PubMed |
| First report on genome wide association study in western Indian population reveals host genetic factors for COVID-19 severity and outcome. | Genomics | 2022 | 35680011 | PubTator, text mining | PubMed |
| Development of a Prognostic Model Based on Pyroptosis-Related Genes in Pancreatic Adenocarcinoma. | Dis Markers | 2022 | 35677632 | PubTator, text mining | PubMed |
| Detailed in vitro analyses of the impact of multimodal cancer therapy with hyperthermia and radiotherapy on the immune phenotype of human glioblastoma cells. | Int J Hyperthermia | 2022 | 35676615 | PubTator, text mining | PubMed |
| Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALL. | Sci Adv | 2022 | 35675405 | PubTator, text mining | PubMed |
| Novel inflammatory biomarkers in thyroid eye disease. | Eur J Endocrinol | 2022 | 35675127 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=46